Erythropoietin (EPO) has been shown to protect neurons from ischemic stroke, but can also
increase thrombotic events and mortality rates in patients with ischemic heart disease. We …

Erythropoietin (Epo) was once thought to act exclusively in the formation of red blood cells.
As recently reviewed by Smith et al.[Cardiovasc. Res. 59 (2003) 538–548], Epo can also act …

Background: Recent studies show that erythropoietin (EPO) plays a protective role in brain
ischemia. In this condition, administration of EPO protects neurons from ischemic damage …

Erythropoietin (EPO) is a hypoxia-induced hormone produced in the kidneys that stimulates
hematopoiesis in the bone marrow. However, recent studies have also shown important …

Erythropoietin has recently been shown to have effects beyond hematopoiesis such as
prevention of neuronal and cardiac apoptosis secondary to ischemia. In this study, we …

Erythropoietin (EPO), originally identified for its critical hormonal role in promoting
erythrocyte survival and differentiation, is a member of the large and diverse cytokine …

Erythropoietin (EPO) is a hormone known to stimulate hematopoiesis. However, recent
research suggests additional properties of EPO, such as protection against …

Objective Erythropoietin (EPO) is a hormone that is currently used to treat patients with renal
failure and anaemia. However, it has also been shown to protect against …

Erythropoietin (EPO) has shown promise as a neuroprotectant in animal models of ischemic
stroke. EPO is thought not only to protect neurons from cell death, but also to promote …

Apart from its hematopoietic function, erythropoietin (Epo) exerts neuroprotective functions in
brain hypoxia and ischemia. To examine the mechanisms mediating Epo's neuroprotective …